ColliersSecurities analyst Barry Oxford maintains $Global Medical REIT Inc(GMRE.US)$ with a buy rating, and maintains the target price at $40.
ColliersSecurities analyst Barry Oxford maintains $Global Medical REIT Inc(GMRE.US)$ with a buy rating, and maintains the target price at $40.